Your audiobook is waiting…

Too Much Information? FDA Clears 23AndMe to Sell Home Genetic Tests for Alzheimer's and Parkinson's

Narrated by: Jef Holbrook
Length: 4 mins

$14.95/month after 30 days. Cancel anytime.

Publisher's Summary

Genetic testing company 23AndMe is back with a controversial new offering, after the U.S. Food and Drug Administration on Thursday green-lighted the company’s request to market a fresh batch of direct-to-consumer tests. Soon, with a simple saliva swab dropped in the mail, customers will be able to get answers about their genetic risk for developing 10 maladies—including Parkinson’s disease and late-onset Alzheimer’s.

"Too Much Information? FDA Clears 23AndMe to Sell Home Genetic Tests for Alzheimer's and Parkinson's" is from scientificamerican.com, published on April 7, 2017.

©2017 Scientific American (P)2017 Scientific American

What members say

No Reviews are Available